Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125606931 | 12560693 | 1 | I | 20160607 | 20160701 | 20160715 | 20160715 | EXP | DE-CIPLA LTD.-2016DE09729 | CIPLA | 0.00 | Y | 0.00000 | 20160715 | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125606931 | 12560693 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK | U | U | 77383 | ||||||||
| 125606931 | 12560693 | 2 | SS | PACLITAXEL ONCOTRADE | PACLITAXEL | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 | ||||||||
| 125606931 | 12560693 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125606931 | 12560693 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125606931 | 12560693 | Back pain | |
| 125606931 | 12560693 | Dyspnoea | |
| 125606931 | 12560693 | Erythema | |
| 125606931 | 12560693 | Hypersensitivity | |
| 125606931 | 12560693 | Pain in extremity | |
| 125606931 | 12560693 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125606931 | 12560693 | 2 | 20160607 | 20160607 | 0 |